IP Library Granted Patent US 8,446,280
Granted Patent B2
US 8,446,280 · App. 12/016,583 · Granted May 21, 2013

Systems and methods for managing information relating to medical fluids and syringes therefor

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,446,280
App. No.
12/016,583
Granted
May 21, 2013
Kind
B2
Abstract

An apparatus and method of operation is provided for a contrast media injector having a powered drive ram. The drive ram is designed to interface with a plunger of a syringe in order to move the plunger forward and backward relative to a barrel of the syringe. The syringe, having an RF data tag associated therewith, is mounted on to the contrast media injector. Electromagnetic signals are transmitted from an electromagnetic device of the injector in response to mounting the syringe. Data is electromagnetically read from the RF data tag of the syringe using the electromagnetic device of the injector. The transmitting is terminated after the electromagnetically reading. Medical fluid is then dispensed from the syringe. Electromagnetic signals are transmitted from the electromagnetic device in response to initiation of the dispensing. Data is electromagnetically written to the RF data tag of the syringe using the electromagnetic device of the injector.

Claims (45)

1. A method of operation for a contrast media injector having a powered drive ram that is designed to interface with a plunger of a syringe to move the plunger of the syringe forward and backward relative to a barrel of the syringe when the syringe is mounted on the contrast media injector, the method comprising:

detecting when a syringe, having an RF data tag associated therewith, has been mounted on to the contrast media injector;

initiating a transmission of electromagnetic signals from an electromagnetic device of the contrast media injector in response to detection of the syringe being mounted on to the contrast media injector; and

electromagnetically reading data generated from the RF data tag of the syringe in response to the transmitted electromagnetic signals.

2. The method of claim 1 , wherein the data that is electromagnetically read comprises at least one of: a syringe identification; a serial number; a use indicator of the syringe; a syringe security code; information relating to syringe volume; information relating to syringe volume delivery; syringe volume; syringe dimension information; medical fluid type; medical fluid concentration data; batch and lot numbers; shelf life data; fill date; and combinations thereof.

3. The method of claim 1 , wherein the initiating a transmission occurs substantially simultaneously with the syringe being mounted on to the contrast media injector.

4. The method of claim 1 , wherein the contrast media injector comprises a latch for securing the syringe that is being mounted on to the contrast media injector, and wherein the initiating a transmission occurs in response to the latch securing the syringe being mounted on to the contrast media injector.

5. The method of claim 4 , wherein the initiating a transmission occurs substantially simultaneously with the latch securing the syringe being mounted on to the contrast media injector.

6. A method of operation for a contrast media injector having a powered drive ram that is designed to interface with a plunger of a syringe to move the plunger of the syringe forward and backward relative to a barrel of the syringe when the syringe is mounted on the contrast media injector, the method comprising:

initiating dispensing medical fluid from a syringe having an RF data tag associated therewith, wherein the dispensing is accomplished using the contrast media injector;

transmitting electromagnetic signals from an electromagnetic device of the contrast media injector in response to initiation of the dispensing; and

electromagnetically writing data to the RF data tag of the syringe using the electromagnetic device of the contrast media injector.

7. The method of claim 6 , wherein the data that is electromagnetically written to the RF data tag comprises at least one of: time that the dispensing was finished; date that the dispensing was finished; dispensed volume; achieved flow rate; target flow rate; volume of medical fluid remaining in the syringe; dispensing time; patient name; patient weight; patient age; patient ID number; injector serial number; injector firmware version; procedure number; procedure name; technologist name; technologist identification number; hospital name; hospital identification number; imaging apparatus information; and combinations thereof.

8. The method of claim 6 , wherein initiation of the transmitting occurs substantially simultaneously with the initiation of the dispensing.

9. A method of operation for a contrast media injector having a powered drive ram that is designed to interface with a plunger of a syringe to move the plunger of the syringe forward and backward relative to a barrel of the syringe when the syringe is mounted on the contrast media injector, the method comprising:

detecting when a syringe, having an RF data tag associated therewith, has been mounted on to the contrast media injector;

transmitting electromagnetic signals from an electromagnetic device of the contrast media injector in response to detection of the syringe being mounted on to the contrast media injector;

electromagnetically reading data from the RF data tag of the syringe using the electromagnetic device of the contrast media injector, wherein the transmitting is terminated after the electromagnetically reading;

initiating dispensing medical fluid from the syringe;

transmitting electromagnetic signals from the electromagnetic device in response to initiation of the dispensing; and

electromagnetically writing data to the RF data tag of the syringe using the electromagnetic device of the contrast media injector.

10. The method of claim 1 , wherein the data that is electromagnetically read includes a use indicator of the syringe.

11. The method of claim 1 , wherein the data that is electromagnetically read includes information relating to syringe volume.

12. The method of claim 1 , wherein the data that is electromagnetically read includes information relating to syringe volume delivery.

13. The method of claim 1 , wherein the data that is electromagnetically read includes a syringe volume.

14. The method of claim 1 , wherein the data that is electromagnetically read includes syringe dimension information.

15. The method of claim 1 , wherein the data that is electromagnetically read includes a medical fluid type.

16. The method of claim 1 , wherein the data that is electromagnetically read includes medical fluid concentration data.

17. The method of claim 1 , wherein the data that is electromagnetically read includes batch and lot numbers.

18. The method of claim 1 , wherein the data that is electromagnetically read includes shelf life data.

19. The method of claim 1 , wherein the data that is electromagnetically read includes a fill date.

20. The method of claim 6 , wherein the data that is electromagnetically written to the RF data tag includes a time that the dispensing was finished.

21. The method of claim 6 , wherein the data that is electromagnetically written to the RF data tag includes a date that the dispensing was finished.

22. The method of claim 6 , wherein the data that is electromagnetically written to the RF data tag includes a dispensed volume.

23. The method of claim 6 , wherein the data that is electromagnetically written to the RF data tag includes an achieved flow rate, a target flow rate, and combinations thereof.

24. The method of claim 6 , wherein the data that is electromagnetically written to the RF data tag includes a volume of medical fluid remaining in the syringe.

25. The method of claim 6 , wherein the data that is electromagnetically written to the RF data tag includes a dispensing time.

26. The method of claim 6 , wherein the data that is electromagnetically written to the RF data tag includes a patient name, a patient age, a patient ID number, and combinations thereof.

27. The method of claim 6 , wherein the data that is electromagnetically written to the RF data tag includes an injector serial number, an injector firmware version, and combinations thereof.

28. The method of claim 6 , wherein the data that is electromagnetically written to the RF data tag includes a procedure number, a procedure name, and combinations thereof.

29. The method of claim 6 , wherein the data that is electromagnetically written to the RF data tag includes a technologist name, a technologist identification number, and combinations thereof.

30. The method of claim 6 , wherein the data that is electromagnetically written to the RF data tag includes a hospital name, a hospital identification number, and combinations thereof.

31. The method of claim 6 , wherein the data that is electromagnetically written to the RF data tag includes imaging apparatus information.

32. The method of claim 1 , wherein the mounting of a syringe is detected using a sensor coupled to a syringe mounting.

33. The method of claim 9 , wherein the mounting of a syringe is detected using a sensor coupled to a syringe mounting.

Assignments (4)
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 032480, FRAME 0001 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: THERAKOS, INC.; MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.); MALLINCKRODT CARRIBEAN, INC.; MALLINCKRODT US POOL LLC; MNK 2011 LLC (F/K/A MALLINCKRODT INC.); LUDLOW LLC (F/K/A LUDLOW CORPORATION); CNS THERAPEUTICS, INC.; MALLINCKRODT ENTERPRISES HOLDINGS LLC (F/K/A MALLINCKRODT ENTERPRISES HOLDINGS, INC.); MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS LLC (F/K/A MALLINCKRODT BRAND PHARMACEUTICALS, INC.); MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC.; MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC (F/K/A VTESSE INC.); MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.); INFACARE PHARMACEUTICAL CORPORATION; ST SHARED SERVICES LLC; IKARIA THERAPEUTICS LLC; INO THERAPEUTICS LLC
Reel/Frame 065609/0322 →
RELEASE OF SECURITY INTEREST Recorded Nov 30, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: LIEBEL-FLARSHEIM COMPANY LLC
Reel/Frame 037172/0094 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 31, 2014
From: MALLINCKRODT LLC
To: LIEBEL-FLARSHEIM COMPANY LLC
Reel/Frame 034715/0531 →
SECURITY INTEREST Recorded Mar 19, 2014
From: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS INC.; MALLINCKRODT CARIBBEAN, INC.; MALLINCKRODT US POOL LLC; MALLINCKRODT INC.; LUDLOW CORPORATION; CNS THERAPEUTICS, INC.; ENTERPRISES HOLDINGS, INC.; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS, INC; MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC; MALLINCKRODT ENTERPRISES HOLDINGS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 032480/0001 →